The row homes from developer The Muskin Company will be completed in early 2026 and priced between $899,000 and $1.1 million.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations Financing ...

GLEN ALLEN, Va., June 11, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing precision ...

UH-60M conducting US Army phase one flight tests of Northrop Grumman's Improved Threat Detection System. (US Army) US Army officials are working with industry counterparts at Northrop Grumman to draft ...

A Zionsville-based developer is preparing for the next phase of development at a 48-acre residential and commercial project along Michigan Road in Zionsville. Pittman Partners plans to build up to 225 ...

TraVure's Phase 4 in Germantown has been revised to a two-story, 34,000-square-foot retail and office building. The new design aims for retail on the ground floor and office space above, potentially ...

BOTHELL, Wash., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (ATHA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs ...